Connect your AI

Iris Acquisition IRAB Issuance of warrants to purchase common stock

Issuance of warrants to purchase common stock at other companies

Ispire Technology Inc.ISPR

$91.49K—

Envoy MedicalCOCH

$882K+348%

CO2 Energy Transition Corp. Common StockNOEM

$51.75K—

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

ADMA BiologicsADMA

$1.4M—

Evommune EVMN

$150—

Other financials

Income statement

Operating income-$144.1K—

Net income$773.9K—

Balance sheet

Cash & equivalents$854.8K—

Total debt$84.6K—

Total equity-$6.4M—

Total assets$170.4M—

Cash flow

Operating cash flow-$9.8K—

Valuation

Market cap$227.44M+0.2%

Enterprise value$226.67M—

Returns & leverage

Debt / equity-0×—

Current ratio2.9×—

Where this comes from

Reported directly by Iris Acquisition in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: Iris Acquisition ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iris Acquisition 's issuance of warrants to purchase common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Iris Acquisition 's issuance of warrants to purchase common stock?: Iris Acquisition (IRAB) reported issuance of warrants to purchase common stock of $334.89K in Q1 2026.